retatrutide type 2 diabetes trial results VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide as a Novel Treatment

T., Wang, J., Wu, H

Sedating antihistamines, certain blood pressure medications, anticholinergic drugs, and others may contribute to mental cloudiness

A near 30% reduction in body weight is substantial

Standard Dosing: 250-500 mcg Per Day The clinical trial tested doses up to 500 mcg daily with no dose-limiting toxicities

Copycat products and inadequate oversight: We already have a troubling market of compounded products, "research" peptides, microdosing plans, longevity packages, and cosmetic weight-loss programs with inadequate medical supervision

Several factors can increase the likelihood of experiencing GLP-1 hair loss: Rate of weight loss: Faster weight loss places greater stress on the body, increasing the chance of telogen effluvium